Harnessing HIV for therapy, basic research and biotechnology.
about
Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected miceNeuroanatomy goes viral!Recent advances in mammalian protein productionSpecific marking of hESCs-derived hematopoietic lineage by WAS-promoter driven lentiviral vectorsBimodal and hysteretic expression in mammalian cells from a synthetic gene circuit.Simplified production and concentration of HIV-1-based lentiviral vectors using HYPERFlask vessels and anion exchange membrane chromatography.Comparative study of the transfection efficiency of commonly used viral vectors in rhesus monkey (Macaca mulatta) brainsVisualization of transfer of a fluorescently-labeled membrane raft protein to T cells using lentivirus.Brainbow: new resources and emerging biological applications for multicolor genetic labeling and analysisGeneration of a lentiviral vector producer cell clone for human Wiskott-Aldrich syndrome gene therapy.Methods for gene transfer to the central nervous system.Clinical-scale lentiviral vector transduction of PBL for TCR gene therapy and potential for expression in less-differentiated cells.New vectors and strategies for cardiovascular gene therapy.New strategies for cardiovascular gene therapy: regulatable pre-emptive expression of pro-angiogenic and antioxidant genesFunctional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells.Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles.Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognitionA simple and effective method to generate lentiviral vectors for ex vivo gene delivery to mature human peripheral blood lymphocytesLentiviral delivery of short hairpin RNAsScaffold-mediated lentiviral transduction for functional tissue engineering of cartilage.New developments in lentiviral vector design, production and purification.Lentiviral vectors for cancer immunotherapy and clinical applicationsCurrent approaches to the diagnosis and treatment of white sponge nevus.Effects of lentiviral vector-mediated TRADD expression on the inhibition of hypertrophic scar formation.Production of lentiviral vectors in protein-free media.Using lentiviral vectors for efficient pancreatic cancer gene therapy.Multiple Sclerosis Gene Therapy with Recombinant Viral Vectors: Overexpression of IL-4, Leukemia Inhibitory Factor, and IL-10 in Wharton's Jelly Stem Cells Used in EAE Mice Model.Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9.Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors.Lentivirus-mediated LIGHT overexpression inhibits human colorectal carcinoma cell growth in vitro and in vivo.Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells.Conditional gene expression: intelligent designs.Generation of stable, high-producing CHO cell lines by lentiviral vector-mediated gene transfer in serum-free suspension culture.Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects
P2860
Q24673105-14956420-A0AA-4BEC-A4CE-8D8C7F0C47DFQ26802140-9B550C3D-8745-402E-B62C-E77E2A91BC1EQ27008285-AA3508C7-D67E-4509-B809-1547B0E49F7AQ28728465-EDF4C36B-5437-41FC-B0C7-DB89EE3B994FQ33340290-1076EDCD-80BE-4A2B-8277-24C11C384F7EQ33409769-5497A3B7-1AAD-4691-BACA-A73FCD445A56Q33577391-4C8AF7C6-3C9E-4745-9685-F7DECB513368Q34872704-75AB1277-1830-4FED-A742-1225590AAFACQ35050861-4AE7FADD-703B-49D4-8A41-D032AF9D141EQ35665052-C681A5D5-2854-4017-A087-DE9419AFE021Q35902332-39E01CD1-F18D-4465-B47B-9B285278BDC8Q36102927-7918EFE4-E8E7-4130-BD3E-E4F0215A28CDQ36174173-BE6ADEF4-8797-4A50-8F45-0E2999BEE794Q36385632-616A9493-8A84-4133-B8D2-EFAC8D50CF03Q37037834-B861FDDF-C031-4182-AE6F-B065505C2B4EQ37068234-703D6FA3-8C3B-44BD-BC39-81DD60C87658Q37197942-93361EE2-6ECC-4A1A-B32C-FDF40963DF3DQ37358371-614F8ECC-7958-4942-9CAD-B60A032E388BQ37430557-06E875BC-862A-4524-AF0F-73FC71C6B90FQ37628097-CACFC04E-2B1B-44FC-93EA-FDE2DF4A40C3Q38099382-F5D14F34-3453-4C75-A6AA-76062B3693E0Q38147100-C25590BC-D705-47AC-B626-1877A473C042Q38506101-F64A88D7-7481-4712-9ABB-63F438C517F0Q38981579-A57B00B5-8FD0-40EE-89F9-104EDAC5DE56Q39576640-6716B02A-5FCC-4254-908F-80707E6BFF53Q39775324-C7F159BE-4CFD-4A29-B356-6DBBB4B47D53Q40072578-BA85AF69-53C1-4880-A53A-E1318F814F0AQ40213297-4F51152F-F129-48A4-8EC1-11974D6BEF2DQ40318203-7338CB40-C737-4514-92D1-23D05E60DF35Q42673095-65F9EAB7-0CEA-48AA-8F29-387A1611FF14Q45406147-A4DE9EF6-5E02-4778-824C-7FBFB3AB073FQ45865358-EB2E9E90-2F60-4858-9668-1F0F1EFB69F2Q50537711-F7B0AAE8-7C79-45B5-AEE3-B463AEE8C348Q57384572-7FBB03CB-3A10-4C40-9DCD-3FDCA4E11A34
P2860
Harnessing HIV for therapy, basic research and biotechnology.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Harnessing HIV for therapy, basic research and biotechnology.
@ast
Harnessing HIV for therapy, basic research and biotechnology.
@en
type
label
Harnessing HIV for therapy, basic research and biotechnology.
@ast
Harnessing HIV for therapy, basic research and biotechnology.
@en
prefLabel
Harnessing HIV for therapy, basic research and biotechnology.
@ast
Harnessing HIV for therapy, basic research and biotechnology.
@en
P1476
Harnessing HIV for therapy, basic research and biotechnology.
@en
P2093
Didier Trono
Maciej Wiznerowicz
P356
10.1016/J.TIBTECH.2004.11.001
P577
2005-01-01T00:00:00Z